Pilar de la Rocha Mur

Sales & Marketing

Pilar de la Rocha Mur is Head of Clinical Operations EMEA (Europe, Middle East, and Africa) at BeiGene.

News

Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.